Form 497 PRUCO LIFE VARIABLE UNIV
PROSPECTUS SUPPLEMENT
PRUCO LIFE INSURANCE COMPANY
Pruco Life Variable Universal Account
PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY
Pruco Life of New Jersey Variable Appreciable Account
Supplement dated May 24, 2022,
to
Initial Summary Prospectuses dated May 1, 2022,
for
VUL Protector® Contracts
This supplement updates and amends certain information contained in the current prospectus and summary prospectus, as applicable, for your variable universal life insurance Contract, as well as any subsequent supplements thereto. You should read this supplement carefully and retain it for future reference.
The Templeton Growth VIP Fund (Class 2) (“the Fund”) has restated its expenses. The following changes apply.
1) The Annual Fee table in the IMPORTANT INFORMATION YOU SHOULD CONSIDER ABOUT THE CONTRACT section is hereby deleted and replaced with the following.
Annual Fee | Minimum | Maximum | ||||||
Investment options (Fund fees and expenses) | 0.29% | 1.16% |
2) The Annual Fund Expenses table in the ADDITIONAL INFORMATION ABOUT FEES section is hereby deleted and replaced with the following.
Annual Fund Expenses | Minimum | Maximum | ||||||
(Expenses that are deducted from the Funds’ assets, including management fees, any distribution and/or service (12b-1) fees, and other expenses, but not including reductions for any fee waiver or other reimbursements.) | 0.29% | 1.16% |
3) The Fund row in APPENDIX A: Funds Available Under the Contract is hereby deleted and replaced with the following.
Type | Fund - Investment Manager(s) / Subadviser(s) | Current Expense | Average Annual Total Returns As Of 12/31/2021 | ||||||||||||||
1 year | 5 year | 10 year | |||||||||||||||
Large-Cap Value | Templeton Growth VIP Fund (Class 2) - Templeton Global Advisors Limited | 1.12%^ | 4.87% | 5.21% | 7.36% |
^ The Fund’s annual current expense reflects temporary fee reductions.
PLEASE RETAIN THIS SUPPLEMENT WITH YOUR PROSPECTUS
PRODUCTSUP170
VULP21
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Medigene AG reports Financial Results and Business Update for Q1 2024
- Progress on ABN AMRO share buyback programme 19 April – 25 April 2024
- Block listing Interim Review
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!